ChemFeeds Site Navigation:
Journal Selection:
Search:

1) Correction: The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells (Molecular Cancer Therapeutics) Tuesday November 4th 2014


2) PDT with a Glucose-Conjugated Chlorin for GIST--Response (Molecular Cancer Therapeutics) Tuesday November 4th 2014


3) PDT with a Glucose-Conjugated Chlorin for GIST--Letter (Molecular Cancer Therapeutics) Tuesday November 4th 2014


4) Stromal Targets of Multikinase Inhibitors (Molecular Cancer Therapeutics) Tuesday November 4th 2014


5) PI3K Pathway Inhibition and Resistance Mechanisms in HNSCC (Molecular Cancer Therapeutics) Tuesday November 4th 2014


6) Camptothecin Tissue Penetration and Activity (Molecular Cancer Therapeutics) Tuesday November 4th 2014


7) The SNAI2:miR145 Axis and Chemotherapeutic Response (Molecular Cancer Therapeutics) Tuesday November 4th 2014


8) The Effect of Irradiation on Multidrug Resistance (Molecular Cancer Therapeutics) Tuesday November 4th 2014


9) Fn14-Targeted Therapeutics (Molecular Cancer Therapeutics) Tuesday November 4th 2014


10) Triple Fusion Protein Targeting Angiogenesis (Molecular Cancer Therapeutics) Tuesday November 4th 2014


11) MEDI-573, Alone or with mTOR Inhibitors, Targets Sarcoma IGF (Molecular Cancer Therapeutics) Tuesday November 4th 2014


12) RG7787 in Gastric and Triple-Negative Breast Cancers (Molecular Cancer Therapeutics) Tuesday November 4th 2014


13) An Antibody-Cytokine-Drug Con{#x0237}ugate with Antitumor Activity (Molecular Cancer Therapeutics) Tuesday November 4th 2014


14) Preclinically Efficacious Antimesothelin-MMAE Con{#x0237}ugate (Molecular Cancer Therapeutics) Tuesday November 4th 2014


15) Preclinical Profile of SYD983/SYD985 (Molecular Cancer Therapeutics) Tuesday November 4th 2014


16) Anti-MET ImmunoPET (Molecular Cancer Therapeutics) Tuesday November 4th 2014


17) Optical Imaging of Prostate Cancer (Molecular Cancer Therapeutics) Tuesday November 4th 2014


18) Inhibition of PSCs by Bisphosphonates in PDAC (Molecular Cancer Therapeutics) Tuesday November 4th 2014


19) Targeting MLL5{beta} for Cervical Cancer Therapy (Molecular Cancer Therapeutics) Tuesday November 4th 2014


20) Monensin Enhances Erlotinib Activity (Molecular Cancer Therapeutics) Tuesday November 4th 2014


21) Efficacy of CH5183284 against Tumors with FGFR Aberrations (Molecular Cancer Therapeutics) Tuesday November 4th 2014


22) Small Molecule Pol I Inhibitors (Molecular Cancer Therapeutics) Tuesday November 4th 2014


23) Pazopanib for FGFR2 Amplification in Gastric Cancer (Molecular Cancer Therapeutics) Tuesday November 4th 2014


24) SEMs for the Treatment of Tamoxifen-Resistant Breast Cancer (Molecular Cancer Therapeutics) Tuesday November 4th 2014


25) Targeting Hypoxia and HR Repair Defects in TNBC (Molecular Cancer Therapeutics) Tuesday November 4th 2014


26) Targeting mTOR Kinase/IGF1R Feedback in Multiple Myeloma (Molecular Cancer Therapeutics) Tuesday November 4th 2014


27) Feedback Loops and Drug Resistance (Molecular Cancer Therapeutics) Tuesday November 4th 2014


28) STK11-Driven Regulation of PDE4D (Molecular Cancer Therapeutics) Thursday October 2nd 2014


29) Zebrafish Antilymphatic Drug Screen (Molecular Cancer Therapeutics) Thursday October 2nd 2014


30) Integrin Deregulation by the Anticancer Gallium Compound KP46 (Molecular Cancer Therapeutics) Thursday October 2nd 2014


31) Regulation of NF-{kappa}B Activation by Piperlongumine (Molecular Cancer Therapeutics) Thursday October 2nd 2014


32) BRCA2 and Gemcitabine (Molecular Cancer Therapeutics) Thursday October 2nd 2014


33) P-Glycoprotein Mediated Resistance to Temozolomide in GBM (Molecular Cancer Therapeutics) Thursday October 2nd 2014


34) OSU-03012 and ER Stress (Molecular Cancer Therapeutics) Thursday October 2nd 2014


35) PTTG1 and Response to Paclitaxel Treatment (Molecular Cancer Therapeutics) Thursday October 2nd 2014


36) Lipid Catabolism Blockade Effects in Prostate Cancer (Molecular Cancer Therapeutics) Thursday October 2nd 2014


37) miR34-Based Cancer Therapy Candidate (Molecular Cancer Therapeutics) Thursday October 2nd 2014


38) IFN{alpha} Enhances T-Cell Killing of Solid Cancers (Molecular Cancer Therapeutics) Thursday October 2nd 2014


39) Targeting Melanoma with Nanolipolee-007 (Molecular Cancer Therapeutics) Thursday October 2nd 2014


40) BET Antagonist and FLT3-TKI against AML Cells (Molecular Cancer Therapeutics) Thursday October 2nd 2014


41) ICG-001 Inhibits Pancreatic Cancer Growth (Molecular Cancer Therapeutics) Thursday October 2nd 2014


42) Simvastatin and Metformin Combination Chemotherapy (Molecular Cancer Therapeutics) Thursday October 2nd 2014


43) Fludarabine Phosphate Repurposed for GIST (Molecular Cancer Therapeutics) Thursday October 2nd 2014


44) Targeting Endoglin in Pancreatic Cancer (Molecular Cancer Therapeutics) Thursday October 2nd 2014


45) Target Vemurafenib Resistance by the CDK4/6 Inhibitor LY2835219 (Molecular Cancer Therapeutics) Thursday October 2nd 2014


46) Correction: The Phosphoinositide 3-Kinase {alpha} Selective Inhibitor BYL719 Enhances the Effect of the Protein Kinase C Inhibitor AEB071 in GNAQ/GNA11-Mutant Uveal Melanoma Cells (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


47) Correction: Driven to Death: Inhibition of Farnesylation Increases Ras Activity in Osteosarcoma and Promotes Growth Arrest and Cell Death (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


48) Correction: Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-{kappa}B Activation, and Is Active in Patient-Derived Xenograft Models (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


49) Predictive Value of EGFL7 in mCRC (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


50) Pharmacogenetic Predictors in Early-Stage Colon Cancer (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


51) Biomarker for CBP501 (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


52) Combination of Quinacrine and Erlotinib in NSCLC (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


53) Novel Human Fusion Protein Kills EpCAM-Positive Cancer Cells (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


54) CDK4/6 Inhibitor Reduces Human Liposarcoma Growth (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


55) Dose Schedule Optimization with Combined MLN8237 and Taxanes (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


56) Cyclopamine Glucuronide Prodrug toward Glioma Stem Cells (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


57) NIR Fluorescent Choline Kinase Inhibitor (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


58) Axl Kinase as an Emerging Key Target for Drug Discovery (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


59) IL15-Secreting MSCs Exert Antitumor Potential (Molecular Cancer Therapeutics) Tuesday August 5th 2014


60) TDP1 and TDP2 Inhibitor Screening (Molecular Cancer Therapeutics) Tuesday August 5th 2014


61) CENP-E Motor Function in Triple-Negative Breast Cancer (Molecular Cancer Therapeutics) Tuesday August 5th 2014


62) Mechanism of Action of the Novel Taxane Cabazitaxel (Molecular Cancer Therapeutics) Tuesday August 5th 2014


63) TGF-Stimulated Mesothelial Cells in Ovarian Cancer Progression (Molecular Cancer Therapeutics) Tuesday August 5th 2014


64) DDX43 Induces RAS Signaling and Drug Resistance (Molecular Cancer Therapeutics) Tuesday August 5th 2014


65) PP2A Inhibitor Sensitizes HCC to Chemotherapy (Molecular Cancer Therapeutics) Tuesday August 5th 2014


66) FAK Controls Ovarian Carcinoma Spheroid Growth (Molecular Cancer Therapeutics) Tuesday August 5th 2014


67) Activity of RG7787 in Pancreatic Cancer Cells (Molecular Cancer Therapeutics) Tuesday August 5th 2014


68) Bispecific HER2-Targeting FynomAb with Superior Activity (Molecular Cancer Therapeutics) Tuesday August 5th 2014


69) s50-TBG-RNAi-CK2 Targets Primary and Metastatic HNSCC (Molecular Cancer Therapeutics) Tuesday August 5th 2014


70) Novel Drug for Treatment of Temozolomide-Resistant Gliomas (Molecular Cancer Therapeutics) Tuesday August 5th 2014


71) AKI603 Attenuates Breast Tumor Initiating Cells (Molecular Cancer Therapeutics) Tuesday August 5th 2014


72) AR-42 Targets AML Stem Cells (Molecular Cancer Therapeutics) Tuesday August 5th 2014


73) A Pragmatic Definition of Therapeutic Synergy (Molecular Cancer Therapeutics) Monday July 7th 2014


74) miR-3607 in Prostate Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


75) miR26b Regulates Cancer Proliferation (Molecular Cancer Therapeutics) Monday July 7th 2014


76) Repositioning Drugs for Renal Cell Cancer Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


77) Mutation Profile of Melanomas Lacking Known Driver Mutations (Molecular Cancer Therapeutics) Monday July 7th 2014


78) BET Bromodomain Inhibition and Pancreatic Cancer Progression (Molecular Cancer Therapeutics) Monday July 7th 2014


79) Antiproliferative Synergism of CK2 and BRAF Inhibitors (Molecular Cancer Therapeutics) Monday July 7th 2014


80) Targeting ER{beta} in SERM-Resistant Breast Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


81) LXR Inhibition of Myeloma Stem Cells (Molecular Cancer Therapeutics) Monday July 7th 2014


82) SIRT1 in the Antitumor Activity of Silybin (Molecular Cancer Therapeutics) Monday July 7th 2014


83) ABT-737 Enhances MEK/mTOR Inhibition-Induced AML Apoptosis (Molecular Cancer Therapeutics) Monday July 7th 2014


84) PIK3R3 Induces EMT, Promoting Metastasis of Colorectal Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


85) MM-121 Combined with Cetuximab in HNSCC Preclinical Models (Molecular Cancer Therapeutics) Monday July 7th 2014


86) Prostate Cancer-Targeted Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


87) Pretargeted RIT of GD2 with an Anti-GD2/DOTA IgG-scFv (Molecular Cancer Therapeutics) Monday July 7th 2014


88) Anti-sEcad mAb-Induced Suppression of Skin SCCs (Molecular Cancer Therapeutics) Monday July 7th 2014


89) Generation of a Canine Anti-EGFR Antibody (Molecular Cancer Therapeutics) Monday July 7th 2014


90) Antibody-Based Delivery of IL2 and Cytotoxics (Molecular Cancer Therapeutics) Monday July 7th 2014


91) Targeting Pancreatic Cancer Stem Cells (Molecular Cancer Therapeutics) Monday July 7th 2014


92) Effect of Metronomic Docetaxel in PRINT Particles and siEZH2 (Molecular Cancer Therapeutics) Monday July 7th 2014


93) Redox-Active Cerium Oxide Nanoparticles in Cancer Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


94) Anti-miR182 Treatment in Ovarian Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


95) GGA Exerts Cardioprotective and Anticancer Effects (Molecular Cancer Therapeutics) Monday July 7th 2014


96) EW-7197, an Antimetastatic Drug in Breast Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


97) Leelamine Inhibits Intracellular Cholesterol Transport (Molecular Cancer Therapeutics) Monday July 7th 2014


98) Targeting Melanomas Using Leelamine (Molecular Cancer Therapeutics) Monday July 7th 2014


View: prev | next

#RealTimeChem:

Announcements:

Chem News Feed:

Rudolf Hoppe (1922 – 2014)

Unit Cell Hell

Excellence in Publishing with ChemXChem

Festive fuels

Obama acts to attract non-US scientists and engineers

10 years ago: periodic poster purchased

Chemistry by the tun

Femtofluidic droplet manipulation now possible

Cool idea for zero-carbon air conditioning that requires no power source

Cleaning up after Fukushima

Conductive clay rolled out to store energy

Engineers Combine 3-D Printing With Ionic Liquids To Make Conductive Materials

Cheap Templates For Solar Cells Now On Blu-Ray

EPA Proposes More Protective Air Pollution Limit For Ground-Level Ozone

Paul Schleyer: Among the last of the universalists


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()